Please enable Javascript
ASH 2021 Sickle Cell News
Could Better Access to Transfusion Services Improve Hospice Enrollment?
Ariel Jones
Conferences
|
December 13, 2021
Patients with hematologic malignancies who may require blood transfusions may not be able to enroll in hospice care.
Read More
ATLAS-INH: Fitusiran Reduces Bleeding Rates in Hemophilia A and B With Inhibitors
Ariel Jones
Conferences
|
December 13, 2021
This clinical outcome translates to meaningful improvement in health-related quality of life, according to researchers.
Read More
Etavopivat Improves Anemia and Hemolysis in Sickle Cell Disease
Ariel Jones
Conferences
|
December 13, 2021
Researchers evaluated the effects of etavopivat in two-week multiple ascending dose cohorts and a 12-week open-label study.
Read More
COVID-19 Vaccination Does Not Increase Risk of Deep Vein Thrombosis
Ariel Jones
Conferences
|
December 13, 2021
Researchers found no increased risk for acute deep vein thrombosis post-vaccination for approved COVID-19 vaccines.
Read More
In Acquired Hemophilia A, Emicizumab Enhances Bleeding Prophylaxis
Ariel Jones
Conferences
|
December 13, 2021
Lead author Jacqueline N. Poston, MD, shared the findings.
Read More
bb1111 Gene Therapy Improves Quality of Life for Sickle Cell Patients
Ariel Jones
Conferences
|
December 13, 2021
The present analysis updates findings from the ongoing phase 1/2 HGB-206 study.
Read More
Women With SCD Are at High Risk of Pregnancy Complications
Ariel Jones
Conferences
|
December 13, 2021
Researchers described the outcomes for pregnant women with SCD, who are considered at high risk for complications.
Read More
Advertisement
Advertisement